ArticleMolecular therapy. Nucleic acids2021

HIF1A-AS2 induces osimertinib resistance in lung adenocarcinoma patients by regulating the miR-146b-5p/IL-6/STAT3 axis.

Jiahui Si et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.